Annexon, Inc. (ANNX) Insider Trading

Over the last 6 months, 86 institutions increased and 53 reduced their position (13F).

Insider Activity

Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price -12.8%Institutions reducing (13F)
DateInsiderTypeSharesPrice
Aug 12, 2026Blumenkranz Mark S.directorGrant175,000$5.39
Jun 15, 2026Choi JungdirectorGrant65,000$4.70
Jun 15, 2026Carson William H.directorGrant65,000$4.70
Jun 15, 2026Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICEROption30,646$1.85
Jun 15, 2026Cockroft Bettina M.directorGrant65,000$4.70
Jun 15, 2026Waddill William D.directorGrant65,000$4.70
Jun 15, 2026Satter Muneer AdirectorGrant65,000$4.70
Jun 15, 2026JONES WILLIAM A JRdirectorGrant65,000$4.70
May 29, 2026Satter Muneer AdirectorBuy613,497$5.41
May 13, 2026Carson William H.directorBuy8,000$5.78
Apr 14, 2026Carson William H.directorBuy8,000$6.20
Mar 12, 2026Carson William H.directorBuy8,000$5.67
Mar 4, 2026ARTIS DEAN RICHARDofficer: EVP & CHIEF SCIENTIFIC OFFICERSell5,894$5.43
Mar 4, 2026Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICERSell5,566$5.42
Mar 4, 2026Lew Jenniferofficer: EVP & CHIEF FINANCIAL OFFICERSell5,565$5.42
Mar 4, 2026Dananberg Jamieofficer: CHIEF MEDICAL OFFICERSell5,820$5.43
Mar 4, 2026Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICERSell4,339$5.42
Feb 23, 2026ARTIS DEAN RICHARDofficer: EVP & CHIEF SCIENTIFIC OFFICERGrant62,500
Feb 23, 2026Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICERGrant62,500
Feb 23, 2026Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICERGrant250,000$5.10
Feb 23, 2026Dananberg Jamieofficer: CHIEF MEDICAL OFFICERGrant225,000$5.10
Feb 23, 2026Dananberg Jamieofficer: CHIEF MEDICAL OFFICERGrant56,250
Feb 23, 2026ARTIS DEAN RICHARDofficer: EVP & CHIEF SCIENTIFIC OFFICERGrant250,000$5.10
Feb 23, 2026Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICERGrant62,500
Feb 23, 2026Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICERGrant250,000$5.10
Feb 23, 2026Lew Jenniferofficer: EVP & CHIEF FINANCIAL OFFICERGrant62,500
Feb 23, 2026Lew Jenniferofficer: EVP & CHIEF FINANCIAL OFFICERGrant250,000$5.10
Feb 23, 2026Love Douglasdirector, officer: PRESIDENT AND CEOGrant1,250,000$5.10
Feb 20, 2026Overdorf Michaelofficer: EVP & CHIEF BUSINESS OFFICERSell6,225$5.10
Feb 20, 2026Yednock Tedofficer: EVP & CHIEF INNOVATION OFFICERSell7,857$5.11

Source: ANNX SEC Form 4 filings, latest Aug 12, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their ANNX positions over the last 6 months (SEC Form 13F).

Increased
86
New positions
68
Reduced
53
Sold out
213
Largest moves
InstitutionActionSharesFiled
REDMILE GROUP, LLCIncreased14.5MMay 15, 2026
BLACKROCK, INC.Increased10.9MMay 13, 2026
FMR LLCIncreased10.6MMay 15, 2026
BVF INC/ILReduced8.7MMay 15, 2026
STATE STREET CORPIncreased6.9MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position6.0MMay 15, 2026
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLCReduced5.2MMay 15, 2026
BELLEVUE GROUP AGUnchanged5.2MMay 15, 2026
MAK CAPITAL ONE LLCIncreased4.7MMay 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Reduced4.3MMay 15, 2026
BANK OF AMERICA CORP /DE/Increased4.3MMay 18, 2026
NUVEEN, LLCIncreased4.2MApr 30, 2026
SIREN, L.L.C.New Position4.0MMay 14, 2026
BALYASNY ASSET MANAGEMENT L.P.Increased3.9MMay 15, 2026
AMERIPRISE FINANCIAL INCReduced3.4MJul 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.